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 Abstract  
Whilst humans evolved in the earth’s Electro-Magnetic-Field (EMF) and sun-light, 
both being essential to life but too much sun and we burn. What happens if 
background EMF rise to critical levels, coinciding with increasing environmental 
pollutants?  
Two of the authors can look back over 50 clinical years and appreciate the profound 
changes in human morbidity across a range of disparate conditions - autoimmune 
diseases, asthma, earlier cancer incidence and reduced male sperm counts. In 
particular have been  increased autism, dyslexia, Attention Deficit Hyperactivity 
Disorder  and neurological diseases, such as Amyotrophic Lateral Sclerosis, Multiple 
Sclerosis, Parkinson’s Disease, Early Onset Dementia, Multiple System Atrophy and 
Progressive Supranuclear Palsy. What might have caused these change- whilst 
genetic factors are taken as given, multiple environmental pollutants are associated 
with neurological disease although the mechanisms are unclear. The pace of 
increased neurological deaths far exceeds any Gompertzian explanation that 
because people are living longer they are more likely to develop more age-related 
problems such as neurological disease.  
Using WHO global mortality categories of Neurological Disease Deaths (NDD) and 
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Alzheimer’s and Dementia deaths (Alz), updated June 2018, together they constitute 
Total Neurological Mortality (TNM), to calculate mortality rates per million for people 
aged 55-74 and for the over-75’s in twenty-one Western countries.  
Recent increases in American people aged over-75’s rose 49% from 1989 to 2015 
but US neurological deaths increased five-fold. In 1989 based on Age-Standardised-
Deaths-Rates America USA was 17th at 324pm but rising to 539pm became second 
highest.  
Different environmental / occupational factors have been found to be associated with 
neuro-degenerative diseases, including background EMF.  We briefly explore how 
levels of EMF interact upon the human body, which can be described as a natural 
antennae and provide new evidence that builds upon earlier research to propose the 
following hypothesis. 
Based upon recent and new evidence we hypothesise that a major contribution for 
the relative sudden upsurge in neurological morbidity in the Western world (1989-
2015), is because of increased background EMF that has become the tipping point-  
impacting upon any genetic predisposition, increasing multiple-interactive pollutants, 
such as rises in petro-chemicals, hormone disrupting chemicals, industrial, 
agricultural and domestic chemicals.  The unprecedented neurological death rates, 
all within just twenty-five years, demand a re-examination of long-term EMF safety 
related to the increasing background EMF on human health. We do not wish to `stop 
the modern world’ , only make it safer. 
Key Words: neurological aetiology Electro-Magnetic-Fields environmental epigenetic 
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Text (4,630). 
Introduction:  
The Hypothesis. 
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It is an evolutionary fact that humans evolved within the Earth’s constant Electro-
Magnetic-Field (EMF) and the sun’s radiation which are essential to life. If there is too 
much sun, we burn but what if there is too much EMF? 
We hypothesise that over the last 25 years increases in background Electro-
Magnetic-Fields within the human environment, impacting upon the extant and rising 
multiple interactive-environmental pollutants is the Tipping Point for the accelerating 
increases in neurological deaths in the Western world 1-13.  For example, impacting 
on rising problems of air pollution, on what has been described as the neuro-
inflammation hypothesis 14,15, whilst increased background of EMF are increasingly 
linked to both neurodegenerative disease and leukaemia, both associated with 
oxidative stress 16. 
To make the case we need to look back at changing environmental pollutants and 
think across disciplines to consider apparently unconnected changes in human 
morbidity. Two of the authors have the advantage of being able to look back over 50 
clinical years and can appreciate the profound changes that have occurred. What is 
often difficult to grasp is how recent are changes in the world environment. There has 
been an explosive development in a wide range of chemicals that have been 
employed by human in the relentless pursuit of mastering our environment.  
The digital world that now surrounds us with new levels of Electro-Magnetic Fields 
[EMFs] and it is the magnetism that might be the problem. Many environmentally 
linked diseases often need 20 or more years to develop 17,18, so as the digital world is 
still a relatively a new phenomenon, the possible twenty years needed for 
pathological effects of raised EMF is perhaps beginning to emerge? 
The first major wake-up call of the impact of environmental pollution upon human 
morbidity was Rachel Carson’s 1968 `Silent Spring’. She highlighted the damage  
to wild-life by environmental degradation and alerted us to the fact that human beings 
are not exempt or immune to environmental pollutants. The slow response to 
emerging scientific alarm bells was seen in the reluctant acceptance of the problem 
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with asbestos, which has led to today a growing epidemic of people entering their 
sixties with asbestos related diseases and with the previously assumed neutral 
organophosphates 17-19. The recent Volkswagen scandal who hid the extent of diesel 
particulates shows we cannot always trust even the most prestigious companies to 
acknowledge inadvertent negative impacts on human health of economic activity.  
We will ignore notable changes in human morbidity such as rises in autoimmune 
disease, allergies, falling sperm counts but focus upon conditions which can be said 
to be broadly neurologically related.  
Attention Deficit Hyperactivity Disorder (ADHD) which was virtually unheard of until 
the 1980’s. It might well be an early soft-neurological sign but reflects undoubted 
change. It was described as `minimal cerebral dysfunction’ and from 1963 onwards it 
took 20 years to have a 100 papers on the medical data base `medline’. Re-defined 
as ADHD in 1987, from January to September 2018 there were 700 papers, from 
across the world. 
Autism, rare before the 1970’s, initially being described as a primarily psychological 
disorder in children of `refrigerator parents’. Now widely recognised and every 
Western country has an Autistic Society, with an estimated 700,000 British people on 
the autistic spectrum with a projected 20million people world- wide 20 . Whilst this may  
be to do with a greater willing to make the diagnosis, does this really explain the 
enormous rise in numbers? 
Another `ambiguous’ condition is Chronic Fatigue Syndrome (CFS) or Myalgic 
Encephalomyelitis (ME) and is still debatable whether it is a `functional’ rather than 
neurological disorder. Two other new but controversial diagnostic categories are 
Electromagnetic Hypersensitivity (EHS) and Multiple Chemical Sensitivity (MCS). 
The first paper on medline for EHS was in 2005 but in the last three years there were 
223. In regard to MCS the first paper was in 1975 and only a second study by 1988 
but in 2018 there were eight such papers.   
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If  ADHD, Autism-Asperger spectrum, Dyslexia and ME / CFS, all initially ascribed to 
children but now diagnosed in adults, are thought of as basically neurological 
disorders this raises the question are there environmental influences related to these 
increased `neurological’ conditions. Plus rises in the established conditions such as 
Motor Neurone and Parkinson’s Diseases etc 1-16? 
It is hypothesised that the impact of Electro-Magnetic-Fields, interacting and 
impacting on top of genetic predisposition and extant and growing multiple 
environmental changes, is the tipping point that triggers these unprecedented 
accelerating rises.  
However, it has to be acknowledged that there are some inconsistent findings 
regarding EMF, as some have found no EMF link with neuro-pathology, or that 
EMFG has been therapeutic 21-27. Alternative explanations, such as the Gompertzian 
hypothesis 28, 29 and improved diagnosis 30 are sometimes used to suggest the rises 
in neurological morbidity are essentially an artefact.  
The major artefact argument is the Gomperptzian hypothesis that explains the raised 
incidence is because people are now living longer to develop aged-related disease,  
so it is argued that the increases mainly reflect improved longevity 28, 29. This 
hypothesis will be evidentially refuted in the course of this study. 
Clinical Studies of Incidence of Neurological Disorders: We briefly explore 
human clinical level studies reporting rises in neurological diseases, especially 
Parkinson’s Disease and Amyotrophic Lateral Sclerosis (ALS), designated Motor 
Neurone Disease in Europe. We have decided to exclude all animal studies, despite 
many results indicating possible aetiological EMF connections but there is always the 
question of transferability to humans. As will be shown, there are sufficient human 
clinical studies to support the EMF tipping point hypothesis.  
 A series of clinical type studies highlighted rises in a range of neurological disease 
such as ALS, could be described as epidemic 1-16, mainly in Western countries but 
reports from other continents are increasing 7-10 and rises in Parkinson’s Disease 
6 
 
adds to the growing burden upon services and families 4, 13. Another notable feature 
over the past decade is the rise in what might be considered the rarer neurological 
conditions such as Multiple System Atrophy and Progressive Supranuclear Palsy 31-
35.  
Nonetheless, it cannot be denied that having proportionally more elderly people 
might well be a minor factor, but when the extent of the changes, based on the latest 
WHO data, updated June 2018, this explanation fails to account for the increases 36. 
A major challenge to the Gompertzian explanation is stalky challenged by evidence 
of the explosive rise in early onset dementias reported in the Western world and 
other continents 37-45. Furthermore, in practice terms the Gompertzian explanation is 
at practical odds with important but different type of evidence found in the need for 
the British Parkinson’s Society to establish a Young Persons section for their 
services, with people under-40’s  and a new British charity, Young Dementia UK that 
has many clients under 50 years old!  It is when these conditions are juxtaposed 
together then the possible connections between the psychical and socio-
psychological environments can be seen.   
New Comparative International Study:   Before considering the inter-related 
multiple causes of neurological conditions, and, addressing the central tenant that 
EMF might be the tipping point for the rises in neurological morbidity, we provide the 
very latest population-based analysis of neurological deaths. This builds upon our 
earlier epidemiological studies 11-13 but extrapolates further from the recently updated  
WHO data 36.  
Table [1] shows the two WHO global neurological categories Nervous Disease 
Deaths (NDD) and Alzheimer & other Dementia (Alz) deaths in Age-Standardised-
Death-Rates (ASDR) – in effect controlled for total population between baseline 
years 1989-912 to 2013-15, which combined gives a Total Neurological Mortality 
(TNM) rate per million (pm) of population 36. 
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The highest TNM was Finland at 911pm, the USA 539pm, the Netherlands and the 
UK 424pm. Over the period 1989 to 2015 this represents rises of 161%, 196%,128% 
and 67% respectively. The lowest countries were Japan at 103pm, Greece 104pm,  
Austria 181pm and Portugal 229pm yet these rates are also equivalent to rises of 
56%, 44%, 46% and 129% respectively, with an overall average rise for the 21 
countries of 90% over the period, all controlled for population. 
A perusal of the table shows that in the 1989-91 period seventeen countries had 
higher NDD rates than Alz but by 2013-15 only eight nations’ NDD rates were higher 
than Alz although both death rates increased over the period.  
A further challenge to the Gompertzian explanation 28-29, is shown in Table [2], which 
compares the increases in population of men and women aged 75+ juxtaposed 
against rises in the Elderly (75+) TNM rates from which to calculate a population and 
Total Neurological (TNM) time ratio. 
The highest rate was Finland at 7,204pm but by 2013-15 had risen to 31,246pm, 
which is 4.33 ratio of change, compared to only 66% rise in the 75+ population, 
yielding an odds ratio of 1:2.61. Followed by the USA at 18056pm, with a five-fold 
75+ TNM increase compared to a 49% rise in population yields a ratio of change of 
1:3.59.  
Other notable population to TNM ratios were Canada 1:4.89, Denmark 1:4.21, 
Sweden 1:3.40, Portugal 1: 3.25, Norway 1:2.97, Netherlands 1:2.77 and the UK 
1:2.49 and six other countries had ratios greater than 1:1.50, only Belgium at 1:0.88 
had greater population rises than TNM, and though Greece and Japan more than 
doubled their TNM over the period they had the next smallest population to TNM 
ratios, 1:1.10 and 1:1.33 respectively.  
 
                                        Insert Table [2] 
Though the Gompertzian explanation of these increases might have made some 
contribution but not at this rate or in such a relatively short time.  Moreover, in 1989-
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91 the USA was 14th highest of the 21 countries but by 2013-15 were second highest 
in the Western world! 
An indication of the speed of change in neurological deaths in the 55-74 year age 
band, which is below the life-expectancy of all the countries is given in Table [3], 
ranked by biggest increase in just the last 10 years. 
Thirteen countries had rises of 20% and more over the decade, the biggest rises 
were in Greece 68%, Japan 50%, albeit starting from a low base and the  
Netherlands at 56%, with ten countries having rises of >30%, including the UK at 
45% and the USA at 32%, though there were slights falls in Belgium and France. In 
the first international comparison of changing patterns of neurological deaths which 
focused upon the 55-74 age band 11, when compared to later studies 12,13, it is clear 
these rates are increasing and accelerating as well as involving more countries as 
the years have unfolded.                     
 
                                   Insert Table [3]         
 
To provide a policy and practice perspective, as rates are statistics but numbers are 
actual people. The numbers of people in Britain and America dying from a 
neurological disorder in the age-band 55-74 will illustrate the speed of change. 
Between 1989 until 2015 the numbers of neurological deaths of people aged 55-74  
in Britain went from 3,518 to 5,177 an effective 47% increase over the period. The 
numbers of Total Neurological Mortality in the UK rose from 27,419 to 90,535, 
equivalent to a 330% rise.  
In the USA, the 55-74 age band numbers grew from 16,608 to 76,244, more than a 
four-fold increase. As to total numbers America went from 68,071 to 409,217, a six-
fold increase. It is questionable whether neurological services have increased in 
anything like these proportions. 
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 What there can be little doubt about is that there an epidemic rise in neurological 
deaths, outstripping any demographic or Gompertzian explanation, or due to 
neurological disease diagnosis becoming more `fashionable’ but surely not at the 
extent of these accelerating changes. 
Therefore our hypothesis asks might the changed pattern of EMF in the human 
environment be the trigger / tipping point impacting upon of any genetic 
predisposition and multiple inter-acting environmental influences?  
Some Aetiological Associations: This raises the question of what might be the 
cause of such changes? Evidence comes from studies that point towards multiple-
interactive- environmental factors. A number of occupational groups have been 
associated with raised ALS 46-52. With similar associations in regard to occupations 
and exposure to a range of chemicals and solvents in regard to Parkinson’s Disease 
53-56. Also there have been indications of background Electro-Magnetic-Fields been 
associated with various neurological conditions 14,54-59. Although, as mentioned 
previously, some studies have shown that short term exposure to low level EMF can 
help improve memory in Alzheimer, and can assist healing of wounds, fractures and 
improve stroke patients 21-27. 
Epigenetics: As with many pathologies there are degrees of under-lying genetic 
predisposition/ vulnerability awaiting the environmental trigger, seen in the 
epigenetics of ALS with its familial and sporadic forms, interacting with genetic 
predisposition influenced by environment 60-66.  
Some research is quite specific about broad environmental triggers interacting with a 
person’s genetic background, with such examples related to solvents, Electro-
Magnetic-Field (EMF) and a range of `natural products’ 18, 48, 52,66-69. Bearing in mind 
the increase in early onset dementias, at unprecedented levels, the epigenetic 
influence is confirmed by a series of studies that show a degree of familial 
inheritance 38, 40,42, 68,69. Finland has long had the highest rate of neurological 
pathology. With some studies showing a degree of familial origins, however, the 
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extent of the recent changes supports the finding that increased rates of neurological 
morbidity are more sporadic than familial in origin 4, 5, 38, 40-43, 54, 60-69.  Moreover, it 
should be remembered that the USA neurological death rate rose from being 14th 
highest to become second highest in the Western world. 
A key paper comes from Finland that explored early onset dementia and interactive 
epigenetic factors, whose rate of increase far exceeds any possible inherent genetic 
or Gompertzian influences but indicates that the logical explanation of the 
environment in which rises in background EMF appears to have played a significant 
and perhaps tipping point to fuel the neurological epidemic 42,43, 70. 
EMF: Impacting Upon Human Neurology: The key question is how does EMF 
affect the brain and human neurology? After all the brain is essentially an electro-
biochemical organ and electrical impulses operate the nervous system, so in one 
sense, the EMFs are unlikely to be `neutral’ on human neurology over time 14. 
Moreover, human’s evolved in the earth’s magnetic field, whose flow can be seen by 
any compass, whilst sunlight is essential for life, too much damages or kills. 
Whereas the increased background Electro-Magnetic-Field on people over the past 
two decades, with the remarkable increases in digital devices, raises the question are 
we beginning to see the negative health impact, especially over the last decade, 
similar to the delayed development of environmental based disorder with a twenty 
year lead-in, such as asbestosis and impact on the previously assumed neutral 
organophosphates 17- 19. 
The EMF comes from a range of social as well as domestic objects such as radar 
power with pulsed MHz and GHz signals, some for microseconds can be very high, 
whilst at a low domestic level wiring creates a EMF with harmonic spikes, which by 
taking a compass close to electric sockets produces observable but noticed magnetic 
field.  Some authorities showed that an accumulating dose of GSM 900-MHz RE-
EMF might have devasting effects on neural stem cells proliferation and 
neurogenesis, leading to differentiation and apoptosis 71- 90.  
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From a recent study in Military Medical Research , the strength of the various EMF 
objects, with which most people come into frequent contact are as follows 82. 
Domestic: - FM Radio Antennas 80-800 MHz.  
            Mobile Phones 453-1980MHz. 
            Microwave ovens 915-2450MHz. 
 
           Cordless phones 1800-1900MHz. 
 
           Bluetooth devices 2450MHz. 
 
Previously hairdryers produced seventeen time the ambient EMF but modern 
hairdryers have now been adapted to emit around 50-60Mhz. 
 Locality:-  Mobile Phone base station 463-2170MHz 
 
          Surgical equipment 2450MHz. 
 
          Wireless Local Radio 2450-5000MHz. 
 
          Radar 30-30,000MHz (300 GHz). 
 
Twenty-five years ago apart from FM radio antennas and domestic TV’s and radio 
the sources of EMFs were not yet in general use! With such a major increase in 
background EMF can we really be sure of its neutrality? When illustrating changes to 
students and asking males to point to where they keep their mobile phones, mainly in 
their trouser pockets, means their gonads are being bathed in between 450-1900 
Mhz, a totally new phenomena on human evolution but space precludes the 
possibility related to falls in male sperm counts 22.  Whilst, an early study showed that 
even at a low frequency such as 50-Hz this could influence sleep patterns 71, but 
crucially the EMF interacts at cell level and at chromosomal level 72-81.  
Burke described in detail the magnetic phenomena on human neurology cellular and 
EMF interaction with the body 81. Whilst, we have generally eschewed studies of the 
impact of EMF on animals, we need to acknowledge that even at very low 
frequencies on simple cell development, such as sea urchins, the impact make a 
dramatic effect on new cell development 82.  
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There are very large numbers and types of charged metallic particles in our bodies 
and brains. The magnetic fields and unpaired electrons that result from charged 
particle movements are part of the chemical bonds holding all matter together. These 
traverse a variety of paths and some will spin.   These two fundamentally different 
types of particle movements are diamagnetic, those with axes orientation patterns 
are called paramagnetic, ferromagnetic, antiferromagnetic, ferromagnetic, 
antiferromagnetic or helical, depending on which pattern of spin-axis orientation is 
stable under given environmental and chemical circumstances.    
Spinning electrons have much larger Magnetic Moments than do spinning nuclei.  
This is because the small mass of an electron makes it spin much faster than any 
nuclei. Thus high levels of Reactive Oxygen Species can be generated in the body. 
Hence the increased EMF in the home such as radios, electric plugs, microwave and 
conductive ovens, TV set computers, as EMF, especially the magnetic component, 
interacts with the intricate electrical activities of the central nervous system as 
synapses which are the core structure that involves the electro-chemical signals that 
direct the body 81. Chronic or over exposure to EMF has been found to alter 
chromosomes and DNA and gene expression 73, 74, 78, 82. It can also disturb the 
mitochondrial ADP phosphorylation process - crucially stem cell functioning, and can 
create apoptosis of neural cells 68, 72-76. The EMF can also influence melatonin 71, 79 
and in particular create oxidative stress 83-86 which is linked to shrinkage of dendritic 
spines in the hippocampus 87-88. All these features appear to be precursors of 
neurological pathology. 
Whilst  other environmental influences might well be interacting with the EMF, such 
as nanoparticles from Petro-chemical pollutants, that can also result in increased in 
oxidative stress, which is associated with the development of neuro-degenerative 
disease 34, 51-59,72-93  
Hence these relatively new EMF effects extenuate the extant multiple environmental 
pollutants, albeit at low, and individually, at officially `safe’ levels! 
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Whilst not forgetting that EMF helps in some conditions low levels of EMF, especially 
over time, exposure to EMF have also been found to be linked with memory 
problems 57,91-96. This apparent inconsistency is highlighted as traumatic EMF, in the 
sense that electric shocks and head injury have also been associated with 
neurodegenerative diseases 97-100. On balance it would appear the pathology occurs 
with high intensity but short duration and low intensity but long and frequent intensity 
100-104 (the Bunsen-Roscoe effect), which might account for the apparent 
inconsistency of EMF being therapeutic 24-27, not unlike radiotherapy for cancer 85-105.    
A key paper on how high gradient EMF afters cell life found that even relatively small 
EMF can crucially change the cell membrane and disturb its biological function 
leading to cell death 106. One study looked at the preventive role of resveratrol in 
reducing oxidative stress in a four-year controlled study of long-term occupational 
exposure to EMF, to find after four years the index group had substantially lower 
cellular damage than controls 105. As there are similar new studies from China and 
Russia does this imply that the safety of workers in the EMF industries is a matter of 
growing interest? 
Electro-MAGNETIC-Fields Tipping Point: The studies that initially led to our 
hypothesis was by Hallberg who analysed Swedish national mortality data on 
Alzheimer’s from 1948 until 2014 59. The graph on increased Alzheimer’s from 1948 
to 1988 rose at an angle of 5 degrees but from 1990 to 2014 the curve rose to a 75 
degree angle. The researchers linked these changes to increases in background 
EMF. The second was a small cluster study examining Motor Neurone Disease in a 
Southern English village to find an eight times the county rate of MND and four times 
the UK national rate 99. The methodological problems of cluster studies were readily 
acknowledged but what was striking was the local geography of the village which 
was aligned with a busy airport, compounded all the environmental health problems 
(chemical, solvent, EMF) associated with airports 32,46,48,51,53,55,85, 91,108. On either side 
of the runway were two large downs. On the West was the airport’s radar equipment 
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and on the East were the county commercial mobile masts. The local geography 
meant that the flight take-off was low for five miles to the village which had an excess 
of MND patients 103. 
There are a range of studies identifying neurological pathology to links with solvents 
67, chemicals 2-4; electronics and IT ,  73-85,106 and occupations that include the former 
46-52,72, 97,102,. Thus this airport, with the relative high density of Petro-chemical, 
nanoparticles and electro-radiation, brought together in one site key interactive 
environmental pollutants 103.  Whilst other studies linking neurological disorders to 
airport environments and risks to airline pilot’s health 32, 106,107.   
Taken together it can be seen that there are strong indications of the increased EMF 
impacting upon human health, both neurological, as well as with some cancers 1,10, 72, 
105, 111, 112.  
However the aetiological issues of neurological disease is complex as quite apart 
from the genetic-environmental, some studies have found a viral link with 
neurological disease 113, another with diabetes 114, alcohol being associated with 
Alzheimer’s 115 and the notable rises in allergies over the past two decades 116, whilst 
an earlier study explored EMF on male reproductive patterns which are known to be 
falling in many Western developed countries 22. 
One very important feature is the role of any under-lying genetic predisposition, 
which might explain why oxidative stress is associated both with the cancers 
neurological diseases. This complicates pinning down the precise interactive 
mechanisms of people living in the same environmental situation but develop 
different conditions or no obvious pathologies, possibly depending on genetic 
predispositions 1-3, 37, 46, 48, 49, 52, 54, 57, 60, 64, 65, 72, 91, 103, 112. 
It would be conclusive if we could accurately measure EMF changes in the human 
environment but all we can do is remind readers of the massive intrusion into our 
world of EMF devices which really only began in the 1990’s.  
Discussion of the Cautionary Principle:  
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There is little doubt that there has been a marked increase in episodic neurological 
disease which seems to be a response changing interactive multiple environmental 
pollution, impacting upon under-lying genetic factors. The question is has the case 
been made that the EMF might be a key tipping point for this hitherto relatively 
ignored neurological epidemic?  
The answer paradoxically, might be found in how the various national and official 
authorities have sought greater awareness of the dangers of EMF that are so helpful 
and convenient to our lives, ranging from mobile phones, PC’s to induction cookers 
81. Early official regulations on the safety of EMF in the USA in 2002 were mildly 
speculative and cautionary 117. Later in 2006 the Committee on `Man and Radiation’ 
was acknowledging that there could be possible health problems 118  whilst in 2016 
the EU called for greater surveillance and investigation of related health problems of 
EMF, crucially it acknowledged that that there were emerging health problems 119. 
Indeed urging an cautionary approach from early to late life and the need for 
importance of radiation studies of workers 105, 107, 120-123. 
From Rachel Carson in 1968 alerting us to the simple fact that humans are affected 
by the environment in which they live which is the very driving force of evolution.  
Recent studies related to ionising radiation related to workers in the nuclear industry 
whilst focusing upon cancers reasserted the precautionary principle found in the use 
of the linear-no-threshold (LNT) dose-response model. This points to the risk being 
related to received doses but acknowledge there are no threshold doses below which 
there is no risk. This might well be true for background EMF impacting upon long 
term human health and development 105. 115,116, 122-126. 
To an extent this paper challenges one of the most exciting human developments, 
the emergence of the universal digital age therefore it may arouse the wrath of 
possible vested interests. We reiterate, we do not want to stop the modern digital age 
but make it safer, as the long term effects of being closely surrounded by new 
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compounded levels electro-magnetism are simply unknown but there are 
symptomatic danger signals. 
This study provides sufficient indicative evidence that we need to proceed, guided by 
the cautionary principle, to re-consider health and safety guidelines in relation to 
compounded increases in EMF and human health, especially neurological. At the 
time of writing this has been given greater urgency as charities with Progressive 
Supranuclear Palsy patients are seeking help under the age of forty, which reflects 
recent major studies of a cohort of MSA patients mean onset of 37 years 31-33, 100. 
Such young people with a dementing neurodegenerative disease would have been 
unknown forty years ago and barely credible thirty years ago.  Neurological disease, 
as with other conditions has a combination of interactive causes but with human 
neurology, which is essentially an electro-biochemical system, the EMF is likely to 
play a significant role.  
Despite the size of the literary review we returned to Medline for the latest papers on 
the topic and despite the continuing inconsistencies. There are current papers 
showing negative associations and one suggesting a nocebo effect, with is the 
reverse of the placebo effect, self-suggestion that something is wrong 127 but the 
further need for caution has not been ruled out. There is beginning to be research 
across the Western world showing a growing sense of urgency related to EMF 
impact upon child and adolescent developing brains 128-130. Whilst the pre-cautionary 
measured introduction the use of Resveratrol which appears to reduce oxidative 
stress and is claimed to be offer some protection against adverse effects of EMF! 105 
The key is to think outside the box and considered what might EMF do to the other 
existing pollutants in the human environment and the number of years it takes to 
develop neurodegenerative diseases, as with other classic environmental induced 
pathology 17,18.  
In closing, we take a backward look over just 25 clinical years to consider the rises in 
the incidence of Autism and Asperger syndrome, Chronic Fatigue Syndrome, ADHD, 
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Early Onset Dementias, rises in the WHO diagnostic categories Nervous Disease 
Deaths and Alzheimer’s and Other Dementia deaths across the Western world, all 
alongside intensive increases in background environmental pollutants and the now  
ubiquitous EMF. Part of the problem is that these influences have been slow and 
insidious and the new digital world, so full of `good things’, perhaps we may need to 
begin to realise that possibly we have opened Pandora’s Box.  There is a need to re-
think the modern world’s impact upon human health and its epigenetic development, 
almost matching as it does climate change, which for so long has relatively been 
denied. 
It is stressed that we do not want to `stop the modern’ EMF world, only make it safer. 
Finally, we close as we began.  It is an evolutionary fact that humans evolved within 
the Earth’s electro-magnetic-filed and the sun’s radiation. If we have too much sun 
we burn so are we beginning to get too much EMF that stirs up the soup of 
interactive multiple-pollutants that impact upon human health?  
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